GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.
10
Funding Rounds
$232.3m
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Name | Phone | Social networks | |
---|---|---|---|
Be***** Gi*** |
|
- | |
Jo** al*** sa*** | - | - | - |
Lu* Va********** | - | - | |
Se*** Pi**** | - | - | - |
Name | Phone | Social networks | |
---|---|---|---|
Be***** Gi*** |
|
- | |
Jo** al*** sa*** | - | - | - |
Pe*** Go******** | - | - | |
C�***** Mo**** | - | - |
The company GenSight Biologics has raised a total of $42.25m in funding over 10 rounds.